Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04753190 · ClinicalTrials.gov registry record · NA

Light Timing Study

A NA study of Sleep and Circadian Rhythm, sponsored by Rush University Medical Center.

Recruiting
Registry status
NA
Development phase
113
Enrollment target
1
Study location

NCT04753190: Recruiting NA study of Sleep and Circadian Rhythm, sponsored by Rush University Medical Center.

NCT04753190 is a NA study of Sleep and Circadian Rhythm that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 113 participants, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04753190, a NA study of Sleep and Circadian Rhythm, is actively recruiting participants, sponsored by Rush University Medical Center.

RECRUITING
Registry status
NA
Development phase
113 participants
Enrollment target
1
Study location

Study Summary

Chronic circadian misalignment and sleep restriction peak during late adolescence, and are associated with morning daytime sleepiness, poor academic performance, conduct problems, depressed mood, suicidal ideation, substance use, insulin resistance, and obesity. Bright light exposure from light boxes can shift rhythms earlier (phase advance) to facilitate earlier sleep onset and reduce morning circadian misalignment and the associated risks. To phase advance circadian rhythms, the investigators' PRCs showed that the ideal time to begin light exposure was slightly before wake-up time and light should be avoided around bedtime because this is when light produces maximum phase delay shifts. An unexpected finding from these results, however, was a second advancing region in the afternoon (\~6 to 9 h after habitual wake-up time) suggesting that afternoon light may have more circadian phase advancing ability than traditionally thought. The overall goal of this mechanistic study is to follow-up on the unexpected PRC findings and test whether individually-timed afternoon light alone and in combination with morning bright light can shift circadian rhythms earlier in older adolescents. Four groups will be compared in a randomized parallel group design: afternoon bright light, morning bright light, morning + afternoon bright light, and a dim room light control. Adolescents will complete a 2-week protocol. After a baseline week with a stable sleep schedule, adolescents will live in the laboratory for 7 days. Sleep/dark and the time of bright light exposure will gradually shift earlier. Bright light (\~5000 lux) will be timed individually based on his/her stable baseline sleep schedule. The first 3-h morning bright light exposure will begin 1 h before wake on the first morning. The first 3-h afternoon bright light exposure will begin 5 h after wake. The morning + afternoon exposures will begin at the same times, but each exposure will be 1.5 h so that a total of 3 h of bright li

Primary Outcome

Saliva sampling for the baseline DLMO will begin 6 hours before baseline bedtime and end 2 hours after baseline bedtime to capture the rise of endogenous melatonin. Sampling for the final DLMO will begin 7 hours before baseline bedtime and end 2 hours after baseline bedtime. Participants remain awake and seated in comfortable recliners in dim light (\< 5 lux), except when they need to use the adjoining restroom (also \< 5 lux). Saliva samples are collected every 30 minutes using Salivettes, The

Interventions

  • BEHAVIORAL Baseline Sleep Satiation and Phase Stabilization
  • BEHAVIORAL Gradually Shifted Sleep

Study Locations (1)

Illinois

  • Rush University Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 113 participants
Start Date 2022-08-22
Est. Completion 2026-06-30
Phase NA
Rush University Medical Center

320 total trials

What NCT04753190 shows while recruiting

NCT04753190 is an interventional study that assigns participants to a tested intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (97% lower).

The record links to 5 conditions, with Sleep appearing as the primary indexed condition, and to 2 interventions - of which Baseline Sleep Satiation and Phase Stabilization is the first listed.

NCT04753190 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT04753190 about?

NCT04753190 is a clinical study titled "Light Timing Study". Chronic circadian misalignment and sleep restriction peak during late adolescence, and are associated with morning daytime sleepiness, poor academic performance, conduct problems, depressed mood, suicidal ideation, substance use, insulin resistance, and obesity. Bright light exposure from light boxe...

What is the current status of trial NCT04753190?

This trial is currently recruiting. It is a NA study. The enrollment target is 113 participants. The study started on 2022-08-22. Estimated completion is 2026-06-30.

What conditions does trial NCT04753190 study?

This clinical trial studies the following conditions: Sleep, Circadian Rhythm, Adolescence, Light, Chronobiology.

What interventions are being tested in trial NCT04753190?

The interventions under investigation include: Baseline Sleep Satiation and Phase Stabilization (BEHAVIORAL), Gradually Shifted Sleep (BEHAVIORAL).

Who is sponsoring clinical trial NCT04753190?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04753190 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04753190's enrollment target sits among peer trials

113 54th of 151 higher than 98 of 151 other Sleep trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00748254 · 113 participants

    Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

  • NCT05799248 · 113 participants · Phase 3

    Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

  • NCT07216105 · 113 participants · Phase 1

    FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

  • NCT07449715 · 113 participants

    Respiration From Pleth Validation

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04753190, the US trial registry maintained by the National Library of Medicine. NCT04753190 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.